Artificial intelligence (AI) has rapidly evolved from a futuristic concept to a central pillar of global technology strategy. In 2025, some of the most valuable AI-focused unicorns—startups valued at over $1 billion—are preparing to tap public markets. These companies are capitalizing on strong investor interest in generative AI, machine learning infrastructure, and enterprise automation.

Here’s a look at the top AI unicorns that could go public in 2025, and why investors are watching them closely.

The initial public offering (IPO) market has long been a space where investors seek early-stage opportunities with transformative potential. Yet, while big-name IPOs often steal the spotlight, the real value sometimes lies beneath the surface. Hidden gems—companies with solid fundamentals, strong growth potential, and little media attention—can deliver outsized returns if identified early. However, finding them requires strategy, diligence, and a deep understanding of what to look for beyond the headlines.

Interest rates are one of the most influential factors in the global capital markets, impacting everything from consumer loans to corporate financing strategies. When it comes to Initial Public Offerings (IPOs), changes in interest rates can have a dramatic effect on how companies are valued, how much capital they can raise, and how investors respond to new listings.

This blog post explores how interest rate movements—whether rising or falling—shape the IPO landscape and influence valuation strategies across sectors.

The fintech sector continues to evolve rapidly, transforming how consumers and businesses manage money, access credit, and invest. In 2025, several high-profile fintech startups are preparing to go public, offering investors a chance to buy into the future of finance. From digital banking to payment infrastructure and AI-powered tools, here are the top fintech IPO candidates and closely watched companies in 2025.

1. Stripe

Stripe, the global payments giant powering transactions for companies like Amazon, Shopify, and Google, remains one of the most closely watched IPO candidates in fintech. Although the company reached a $95 billion valuation in 2021, it conducted a successful internal share sale in February 2025 valuing it at $91.5 billion, signaling renewed investor confidence after a temporary decline in earlier years.

Investing in an IPO can be both exciting and risky. Before buying into a newly public company, it’s essential to review its prospectus—officially known as the S-1 filing in the United States. This legal document, filed with the Securities and Exchange Commission (SEC), contains everything an investor needs to make an informed decision. But with dozens (sometimes hundreds) of pages filled with jargon, where do you start?

In this guide, we’ll break down how to read an IPO prospectus like a pro, helping you identify critical sections, assess financials, and spot red flags.

Initial Public Offerings (IPOs) can be thrilling opportunities for investors and companies alike. For companies, it’s a chance to raise capital, expand operations, and gain visibility. For investors, it’s the promise of buying early into the next big thing. But not all IPOs deliver on that promise. In fact, many fall short—and some fail miserably.

So why do some IPOs go from hotly anticipated to market flops? Let’s explore the most common red flags that often signal IPO trouble before it even begins.

Initial Public Offerings (IPOs) can offer exciting opportunities to invest early in companies transitioning to public markets. However, evaluating an IPO requires a disciplined and strategic approach. With companies often presenting a best-case scenario in their prospectus, investors need to know what to look for — and what to question. This guide explores the key factors to evaluate before investing in any IPO.

Understand the Company’s Business Model

Before investing, ask: What does the company do? How does it make money? Is the business model scalable? A company with a clear, understandable, and proven business model is generally a safer investment than one relying on unproven concepts or future technologies that are still in development.

When private companies decide to go public, they typically choose between two primary options: an Initial Public Offering (IPO) or a Direct Listing. While both methods achieve the same end goal—making shares available for public trading—they differ significantly in terms of process, costs, regulatory obligations, and strategic implications. Understanding these differences is key for investors and founders alike.

What is an Initial Public Offering (IPO)?

An IPO is the traditional route for a company to go public. It involves issuing new shares to the public to raise fresh capital. In this process, companies work with underwriters (usually large investment banks) to determine pricing, handle regulatory paperwork, and generate investor interest through a roadshow. The company receives proceeds from the newly issued shares, which are typically used to fund operations, pay down debt, or invest in growth.

The biotechnology sector continues to be a focal point for investors seeking groundbreaking innovations and substantial growth opportunities. As we progress through 2025, several biotech companies are preparing to make their debut on the public markets. This article provides an overview of the top biotech IPOs to watch this year, highlighting their key developments, financial health, and potential market impact.

1. Metsera, Inc.

Metsera, founded in 2022 by ARCH Venture Partners and Population Health Partners, has rapidly positioned itself as a notable player in the weight-loss therapeutics arena. The company’s primary focus is on developing both injectable and oral drugs targeting obesity, utilizing the GLP-1 mechanism among other biological pathways. Their lead product candidate, MET-097i, an injectable formulation, demonstrated promising results in mid-stage trials, showing an average weight loss of 11.3% in patients.

The IPO market is gearing up for a thrilling year as 2025 promises a lineup of high-profile companies preparing to go public. From AI innovators to green energy pioneers and consumer tech giants, investors are watching closely. Here, we highlight some of the most anticipated IPOs of 2025 and why they could shape the future of the public markets.

1. Stripe

Stripe, founded in 2010 by brothers Patrick and John Collison, has become a cornerstone in the fintech industry by providing comprehensive online payment processing solutions. The company’s platform enables businesses of all sizes to accept payments, manage revenue, and expand their operations globally. Over the years, Stripe has garnered a substantial client base, including industry giants like Amazon, Google, and BMW, underscoring its pivotal role in the digital economy.